Media center
Press release
Owkin announces first patient dosed in Phase 1 Clinical Trial of OKN4395, a first-in-class EP2/EP4/DP1 triple inhibitor for patients with solid tumors
January 30, 2025
Press release
Owkin announces first patient dosed in Phase 1 Clinical Trial of OKN4395, a first-in-class EP2/EP4/DP1 triple inhibitor for patients with solid tumors
January 30, 2025
Explore
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Press release
Aster Insights and Owkin collaborate to accelerate research in breast cancer
April 12, 2024
Aster Insights and Owkin collaborate to accelerate research in breast cancer
April 12, 2024
In the media
Owkin has been named one of Forbes’ AI 50
April 11, 2024
Owkin has been named one of Forbes’ AI 50
April 11, 2024
Press release
Jean-Jacques Bienaimé appointed Chairman of the Board at Owkin
March 25, 2024
Jean-Jacques Bienaimé appointed Chairman of the Board at Owkin
March 25, 2024
Press release
Owkin expands collaboration with Sanofi to apply AI for drug positioning in immunology
March 21, 2024
Owkin expands collaboration with Sanofi to apply AI for drug positioning in immunology
March 21, 2024
Press release
Owkin and University Hospitals Birmingham apply AI diagnostics for colorectal cancer
March 19, 2024
Owkin and University Hospitals Birmingham apply AI diagnostics for colorectal cancer
March 19, 2024
In the media
Palmares des inventeurs 2024 : les lauréats de la Biotech Comment mettre sur pied une médecine de précision
February 29, 2024
Palmares des inventeurs 2024 : les lauréats de la Biotech Comment mettre sur pied une médecine de précision
February 29, 2024
Le Point
In the media
Google DeepMind alumni unveil Bioptimus: Aiming to build first universal biology AI model
February 20, 2024
Google DeepMind alumni unveil Bioptimus: Aiming to build first universal biology AI model
February 20, 2024
VentureBeat
In the media
Bioptimus raises $35 million seed round to develop AI foundational model focused on biology
February 20, 2024
Bioptimus raises $35 million seed round to develop AI foundational model focused on biology
February 20, 2024
TechCrunch
In the media
Bioptimus nabs $35M to accelerate biology research with AI
February 20, 2024
Bioptimus nabs $35M to accelerate biology research with AI
February 20, 2024
SiliconAngle
In the media
La startup Bioptimus, mêlant biologie et IA, se lance après avoir levé 35 millions de dollars
February 20, 2024
La startup Bioptimus, mêlant biologie et IA, se lance après avoir levé 35 millions de dollars
February 20, 2024
Maddyness
In the media
Bioptimus, la start-up française qui veut devenir le ChatGPT de la biologie
February 20, 2024
Bioptimus, la start-up française qui veut devenir le ChatGPT de la biologie
February 20, 2024
Les Echos
In the media
This AI startup founded by ex-Googlers just raised $35 million. Check out the 12-slide pitch deck Bioptimus used to land the funds
February 20, 2024
This AI startup founded by ex-Googlers just raised $35 million. Check out the 12-slide pitch deck Bioptimus used to land the funds
February 20, 2024
Business Insider